Lucy Godley to High-Throughput Nucleotide Sequencing
This is a "connection" page, showing publications Lucy Godley has written about High-Throughput Nucleotide Sequencing.
Connection Strength
1.422
-
Identifying potential germline variants from sequencing hematopoietic malignancies. Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):219-227.
Score: 0.600
-
Identifying potential germline variants from sequencing hematopoietic malignancies. Blood. 2020 11 26; 136(22):2498-2506.
Score: 0.599
-
Somatic mutation panels: Time to clear their names. Cancer Genet. 2019 06; 235-236:84-92.
Score: 0.134
-
Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies. Genet Med. 2021 01; 23(1):211-214.
Score: 0.037
-
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC). Clin Lymphoma Myeloma Leuk. 2016 07; 16(7):417-428.e2.
Score: 0.027
-
TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia. Cancer Res. 2015 Jul 15; 75(14):2833-43.
Score: 0.025